Batu Biologics Raises $1Million in Seed Funding to Target Lung Cancer
Lung Cancer, News
Batu Biologics, a immuno-oncology company focused on the development and commercialization of novel therapies that target the blood vessels of tumors, recently announced the completion of a seed funding round ... Read more